For Families

Hearing the “C” word is just the beginning of a long and difficult journey for the patient and their family.

  • During radiation treatments, kids are incredibly vulnerable. They are alone, kept apart from their parents and others, and surrounded by big, loud machines in dark and dreary rooms. Separation anxiety looms large and kids (and parents) dread treatment days.
  • RadFlix aims to give radiation treatments a radical overhaul by creating an emotionally safer experience for patients and their families!

RadFlix is a unique, game-changing system that allows patients to watch their favorite movies during radiation.

This revolutionary new approach to pediatric radiation treatments means:

  • Video-based distraction therapy that can reduce anxiety for all ages helping bringing
    back some of the joys of childhood
  • Younger patients who wouldn’t previously tolerate therapy without anesthesia, are
    willing to do this type of treatment while awake
  • Patients say time goes by faster and they have less fear during radiation
  • Kids feel like they have some control during treatment

Radically Quick Facts

  • RadFlix has been rigorously tested at University of Colorado to make it robust, reliable, and functional
  • Radiation therapists can set up the procedure in one minute and take it down in 20 seconds.
  • In 2022, RadFlix established a partnership with the highly trusted and impactful Morgan Adams Foundation for funding and fundraising.
  • Today, RadFlix is offered to every pediatric patient at UCHealth and we have treated
    over 150 children with phenomenal feedback from patients and families.

About The Morgan Adams Foundation

The Morgan Adams Foundation (MAF) funds kids’ cancer research.  MAF raises awareness of, and educates communities about, the need for pediatric and young adult specific cancer treatments.

Working with leading researchers and physicians, MAF funds new and innovative ideas that will improve cancer treatment effectiveness, overall outcomes, survival rates and quality of life while minimizing the devastating side effects current treatments have on our children.

MAF’s particular interest is to provide seed and bridge grants for viable investigations not yet ripe enough for total funding by larger organizations. Additionally, they are able to partially fund translational studies, experimental therapeutics studies, and/or Phase I and II clinical trials on a case-by-case basis.

MAF increasingly seeks projects that are highly collaborative and/or multi-institutional in nature. Their hope is that they can facilitate, through strategic funding, more rapid clinical trial development to get the best possible treatment options into circulation as expediently as possible.

Through careful consideration and placement of our funding, MAF encourages and supports research intended to improve treatment effectiveness, treatment outcomes, and the quality of life for children battling cancer.